117 related articles for article (PubMed ID: 32886805)
1. Frequent neck US in papillary thyroid cancer likely detects non-actionable findings.
Sek KS; Tsang I; Lee XY; Albaqmi OH; Morosan Allo YJ; Rosmarin MC; Mahrous AK; Parameswaran R; Ng DCE; Tong AKT; Loke KSH; Brenta G; Alghamdi AH; Albati NA; Fish SA; Tuttle RM; Yang SP
Clin Endocrinol (Oxf); 2021 Mar; 94(3):504-512. PubMed ID: 32886805
[TBL] [Abstract][Full Text] [Related]
2. Frequent screening with serial neck ultrasound is more likely to identify false-positive abnormalities than clinically significant disease in the surveillance of intermediate risk papillary thyroid cancer patients without suspicious findings on follow-up ultrasound evaluation.
Peiling Yang S; Bach AM; Tuttle RM; Fish SA
J Clin Endocrinol Metab; 2015 Apr; 100(4):1561-7. PubMed ID: 25632970
[TBL] [Abstract][Full Text] [Related]
3. SERIAL NECK ULTRASOUND IS MORE LIKELY TO IDENTIFY FALSE-POSITIVE ABNORMALITIES THAN CLINICALLY SIGNIFICANT DISEASE IN LOW-RISK PAPILLARY THYROID CANCER PATIENTS.
Yang SP; Bach AM; Tuttle RM; Fish SA
Endocr Pract; 2015 Dec; 21(12):1372-9. PubMed ID: 26372300
[TBL] [Abstract][Full Text] [Related]
4. Papillary Thyroid Carcinoma Recurrence: Low Yield of Neck Ultrasound With an Undetectable Serum Thyroglobulin Level.
Epstein S; McEachern R; Khot R; Padia S; Patrie JT; Itri JN
J Ultrasound Med; 2018 Oct; 37(10):2325-2331. PubMed ID: 29498418
[TBL] [Abstract][Full Text] [Related]
5. Patients with Papillary Thyroid Carcinoma at Intermediate Risk of Recurrence According to American Thyroid Association Criteria Can Be Reclassified as Low Risk When the Postoperative Thyroglobulin Is Low.
Rosario PW; Furtado Mde S; Mourão GF; Calsolari MR
Thyroid; 2015 Nov; 25(11):1243-8. PubMed ID: 26359309
[TBL] [Abstract][Full Text] [Related]
6. Ultrasonography surveillance in papillary thyroid carcinoma patients after total thyroidectomy according to dynamic risk stratification.
Yoon J; Yoon JH; Han K; Lee J; Kim EK; Moon HJ; Park VY; Kwak JY
Endocrine; 2020 Aug; 69(2):347-357. PubMed ID: 32449109
[TBL] [Abstract][Full Text] [Related]
7. Utility of routine ultrasonography follow-up after total thyroidectomy in patients with papillary thyroid carcinoma: a single-center study.
Park HK; Kim DW; Ha TK; Heo YJ; Baek JW; Lee YJ; Cho YJ; Lee DK; Kim DH; Jung SJ; Ahn KJ; Ahn HS; Baek HJ
BMC Med Imaging; 2018 May; 18(1):12. PubMed ID: 29764382
[TBL] [Abstract][Full Text] [Related]
8. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
[TBL] [Abstract][Full Text] [Related]
9. Thyroid Ultrasound: More Sensitive than Radioactive Iodine Imaging in Detecting Recurrence of Papillary Thyroid Cancer in Two Pediatric Patients.
Wise-Oringer BK; Goldis M; Regelmann MO; Klein M; Machac J; Kotlus Rosenberg H; Rapaport R
Horm Res Paediatr; 2018; 90(1):66-72. PubMed ID: 29804120
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of routine ultrasonographic surveillance of patients with low-risk papillary carcinoma of the thyroid.
Wang LY; Roman BR; Palmer FL; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
Surgery; 2016 May; 159(5):1390-5. PubMed ID: 26747227
[TBL] [Abstract][Full Text] [Related]
11. Neck Ultrasound in Patients with Follicular Thyroid Carcinoma.
Segkos K; Porter K; Senter L; Ringel MD; Nabhan FA
Horm Cancer; 2018 Dec; 9(6):433-439. PubMed ID: 30088223
[TBL] [Abstract][Full Text] [Related]
12. Dynamic risk stratification system in post-lobectomy low-risk and intermediate-risk papillary thyroid carcinoma patients.
Cho JW; Lee YM; Lee YH; Hong SJ; Yoon JH
Clin Endocrinol (Oxf); 2018 Jul; 89(1):100-109. PubMed ID: 29672893
[TBL] [Abstract][Full Text] [Related]
13. Thyroid Cancer Patients With No Evidence of Disease: The Need for Repeat Neck Ultrasound.
Grani G; Ramundo V; Falcone R; Lamartina L; Montesano T; Biffoni M; Giacomelli L; Sponziello M; Verrienti A; Schlumberger M; Filetti S; Durante C
J Clin Endocrinol Metab; 2019 Nov; 104(11):4981-4989. PubMed ID: 31206157
[TBL] [Abstract][Full Text] [Related]
14. Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients.
Lamartina L; Montesano T; Trulli F; Attard M; Torlontano M; Bruno R; Meringolo D; Monzani F; Tumino S; Ronga G; Maranghi M; Biffoni M; Filetti S; Durante C
Endocrine; 2016 Nov; 54(2):467-475. PubMed ID: 26668060
[TBL] [Abstract][Full Text] [Related]
15. Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
Llamas-Olier AE; Cuéllar DI; Buitrago G
Thyroid; 2018 Oct; 28(10):1311-1317. PubMed ID: 30105948
[TBL] [Abstract][Full Text] [Related]
16. IS IT WORTH SUPPRESSING TSH IN LOW- AND INTERMEDIATE-RISK PAPILLARY THYROID CANCER PATIENTS BEFORE THE FIRST DISEASE ASSESSMENT?
Lamartina L; Montesano T; Falcone R; Biffoni M; Grani G; Maranghi M; Ciotti L; Giacomelli L; Ramundo V; Lomonaco C; Di Gioia CR; Piernatale L; Ronga G; Durante C
Endocr Pract; 2019 Feb; 25(2):165-169. PubMed ID: 30383494
[TBL] [Abstract][Full Text] [Related]
17. Can the follow-up of patients with papillary thyroid carcinoma of low and intermediate risk and excellent response to initial therapy be simplified using second-generation thyroglobulin assays?
Rosario PW; Mourão GF; Calsolari MR
Clin Endocrinol (Oxf); 2016 Oct; 85(4):596-601. PubMed ID: 26940991
[TBL] [Abstract][Full Text] [Related]
18. Is TSH suppression still necessary in intermediate- and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL before the first disease assessment?
Tian T; Huang R; Liu B
Endocrine; 2019 Jul; 65(1):149-154. PubMed ID: 30924085
[TBL] [Abstract][Full Text] [Related]
19. The role of neck ultrasound in the follow-up of low- and intermediate- risk papillary thyroid cancer.
de Campos Lopes SG; Dias Silva Ferreira DN; Fernandes VAR; da Costa Cardoso Marques HM; da Silva Santos Pereira RF; Monteiro AMC
Arch Endocrinol Metab; 2022 Sept 08; 66(4):481-488. PubMed ID: 35758832
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems.
Pitoia F; Bueno F; Urciuoli C; Abelleira E; Cross G; Tuttle RM
Thyroid; 2013 Nov; 23(11):1401-7. PubMed ID: 23517313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
